Pilar Cacheiro
banner
pilarcacheiro.bsky.social
Pilar Cacheiro
@pilarcacheiro.bsky.social
Computational biologist. Genetics of Rare Diseases, Essential Genes, Statistics, R.
Honesty matters.
I guess art is there for us to agree or disagree with.
August 15, 2025 at 10:27 PM
If I ever get rich I won't tell anyone, but there will be signs.
August 2, 2025 at 1:32 PM
So long, and thanks for all the fish.
July 29, 2025 at 7:19 PM
Not entirely sure what the lunch menu is, but it sure made fishing look easy.
July 27, 2025 at 1:08 PM
If you were a gannet, where would you want to live?
July 25, 2025 at 7:10 PM
We all need a rest sometimes.
July 24, 2025 at 11:15 AM
I've been to conference venues with worse views.
July 1, 2025 at 2:02 PM
So many chairs. For people to enjoy themselves. For free. It often feels like you always have to spend money to have fun. Not if you are resourceful. The kind of resources that matter.
June 30, 2025 at 9:26 PM
June 29, 2025 at 7:37 PM
Ceci n'est pas Londres.
June 28, 2025 at 5:33 PM
Lizzie Radford.

Saturation Genome Editing in SLC2A1. Essentiality screens to assess the impact of VUS.

#CCG2025
June 13, 2025 at 10:24 AM
Good science ✔️
New ideas ✔️
Stimulating chats ✔️
A proper summer night ✔️

This is life being gentle to me.
June 12, 2025 at 8:45 PM
Veronica Kinsler. Beautiful talk on mosaic disorders.

#CCG2025
June 12, 2025 at 11:49 AM
There are worse places to wake up to.
June 12, 2025 at 6:59 AM
Steven Harrison on ACMG standards for sequence variant classification.

#CCG2025
June 11, 2025 at 1:55 PM
Only one shall pass.
May 31, 2025 at 11:16 AM
Never not a good option
May 29, 2025 at 5:50 PM
Hye In Kim. " Human knockouts" in the Genes and Health cohort.

#ESHG2025
May 27, 2025 at 10:21 AM
Aisha Hanaya Alsuwadi on the UAE Genome Program. Love this slide. From population genetics to personalised medicine.

#ESHG2025
May 27, 2025 at 10:15 AM
Georgios Kalantzis. Many more knockouts not previously described, lilely due to hugh autozygosity.

#ESHG2025
May 27, 2025 at 9:58 AM
Georgios Kalantzis. Second time this morning that highlights the need to expand beyond additive effects in GWAS.

@ESHG2025
May 27, 2025 at 9:55 AM
James Ware shows optimism about the clinical use and potential for therapeutic target discovery of genetic modifiers.

#ESHG2025
May 27, 2025 at 8:31 AM
James Ware.Polygenic scores predict penetrance with clinically useful effect sizes.

#ESHG2025
May 27, 2025 at 8:22 AM
James Ware.Genetic background as a modifier of penetrance: Polygenic contribution to monogenic Hypertrophic cardiomyopathy.

#ESHG2025
May 27, 2025 at 8:20 AM
James Ware. The majority of cardiomyopathy cases do not have an identified monogenic cause.

#ESHG2025
May 27, 2025 at 8:08 AM